Related Experiment Video
Updated: Nov 25, 2025

Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes
Published on: August 20, 2015
HPV-inactive cell populations arise from HPV16-transformed human keratinocytes after p53 knockout
Fadi Abboodi1, Phillip Buckhaults2, Diego Altomare2
1Department of Pathology, Microbiology, & Immunology, School of Medicine, University of South Carolina, USA; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, USA; Department of Pediatrics, Mosul Medical College, University of Mosul, Iraq.
Abstract:
HPV-inactive head and neck and cervical cancers contain HPV DNA but do not express HPV E6/E7. HPV-positive primary head and neck tumors usually express E6/E7, however they may produce HPV-inactive metastases. These observations led to our hypothesis that HPV-inactive cancers begin as HPV-active lesions, losing dependence on E6/E7 expression during progression. Because HPV-inactive cervical cancers often have mutated p53, we investigated whether p53 loss may play a role in the genesis of HPV-inactive cancers. p53 knockout (p53-KO) by CRISPR-Cas9 resulted in a 5-fold reduction of E7 mRNA in differentiation-resistant HPV16 immortalized human keratinocytes (HKc/DR). E7 expression was restored by 5-Aza-2 deoxycytidine in p53 KO lines, suggesting a role of DNA methylation in this process. In-situ hybridization showed that p53 KO lines consist of mixed populations of E6/E7-positive and negative cells. Hence, loss of p53 predisposes HPV16 transformed cells to losing dependence on the continuous expression of HPV oncogenes for proliferation.
Insights
Loss of p53 function in human papillomavirus (HPV) 16-infected cells reduces viral oncogene E7 expression and dependence on HPV. This suggests p53 loss may initiate HPV-inactive cancers.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Human papillomavirus (HPV)-inactive cancers possess HPV DNA but lack viral oncoprotein expression.
- HPV-positive tumors can develop inactive metastases, suggesting a loss of viral oncogene dependence during cancer progression.
Purpose of the Study:
- To investigate the role of p53 loss in the development of HPV-inactive cancers.
- To test the hypothesis that HPV-inactive cancers originate from active lesions that lose E6/E7 dependence.
Main Methods:
- CRISPR-Cas9 was used to create p53 knockout (p53-KO) in HPV16-immortalized human keratinocytes (HKc/DR).
- Quantitative analysis of E7 mRNA levels and in-situ hybridization were performed.
- The effect of 5-Aza-2 deoxycytidine on E7 expression in p53-KO cells was assessed.
Main Results:
- p53 knockout led to a significant reduction in HPV16 E7 mRNA levels.
- DNA methylation inhibition restored E7 expression in p53-KO cells.
- p53-KO cell populations showed a mix of E6/E7-positive and negative cells.
Conclusions:
- Loss of p53 function predisposes HPV16-transformed cells to downregulate viral oncogene expression.
- This downregulation suggests a mechanism for the genesis of HPV-inactive cancers, where cells become independent of continuous HPV oncogene activity.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Negative Regulator Molecules

